gene expression analysis Apr 27, 2021 BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker Research Apr 20, 2021 Prostate Cancer Study Shows Oncotype DX GPS Test Accurately Measures Long-Term Outcomes Premium Apr 7, 2021 Qlucore Raises SEK 30M as it Looks Toward IPO Mar 18, 2021 Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests Premium Mar 16, 2021 Cofactor Genomics Cements Clinical Diagnostic Plans as Immunotherapy Prediction Data Builds Premium Jan 26, 2021 Researchers ID Four Small Cell Lung Cancer Subtypes, Suggest Future Treatment Implications Premium Jan 20, 2021 Biotheranostics' Breast Cancer Index Included in Latest NCCN Guidelines Jan 5, 2021 Hologic to Acquire Molecular Diagnostics Firm Biotheranostics for $230M Dec 22, 2020 Agendia FLEX Registry Powers Genomics Research on Underrepresented Breast Cancer Patients Premium Dec 10, 2020 Exact Sciences Oncotype DX Identifies Postmenopausal Breast Cancer Patients Who Can Forgo Chemo Premium Nov 19, 2020 Exceptional Responders Cancer Study Points to Possible Treatment Targets Premium Nov 10, 2020 BostonGene, Thomas Jefferson University Partner on Head, Neck Cancer Research May 30, 2020 Pediatric Precision Oncology Study Matches 28 Percent of Patients to Targeted Therapies Jan 22, 2020 B Cell Gene Expression Profiling May Enable Cancer Immunotherapy CDx Test Premium Dec 12, 2019 Molecular Subgroup May Benefit From Less Toxic CDK4/6 Treatment in ER+ Neoadjuvant Setting Nov 7, 2019 Colorectal Cancers Dial up Mutability in Response to Targeted Treatments Oct 28, 2019 ACT Genomics, UCSD Partner for Tumor Microenvironment Immunotherapy Study Sep 30, 2019 TAILORx High-Risk Group Analysis Adds to Oncotype DX Chemo-Prediction Data Jul 31, 2019 Thermo Fisher, Genome Canada Ink C$6M Collaboration on Cancer NGS Assays Jun 28, 2019 Competing Breast Cancer Assays Beat Genomic Health's Oncotype Dx in Canadian Cost Modeling Study Premium Load More Breaking News Enhertu Shows Activity in Early-Stage HER2-Low Breast Cancer Patients in Study Reported at SABCS Dragonfly Therapeutics Begins Phase II Trial of HER2-Targeted NK-Cell Engager Touchlight to Provide DNA Vector for Odimma Therapeutics' Personalized Neoantigen Vaccine Trial FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Akeso, Summit Therapeutics Ink $5B Licensing Deal for PD-1/VEGF Bispecific Antibody
